CJC-1295 No DAC / Ipamorelin Blend
This pre-blended formulation combines CJC-1295 No DAC (Mod GRF 1-29) with Ipamorelin, the two most-studied compounds in the research community for synergistic growth hormone secretion modeling. The combination allows researchers to study the coordinated effect of a GHRH analogue paired with a selective ghrelin-receptor agonist in a single, reconstitution-ready vial.
Research Areas
- •Growth hormone synergy
- •GH/GHRH axis
- •Body composition
- •Recovery protocols
Molecular Specifications
Molecular Formula
Blend
Molecular Weight
Blend
Purity
≥98.0% (each)
Select Size
Prices are subject to change. Final pricing will be confirmed at checkout.
Certificates of Analysis
Current batch test results for CJC-1295 No DAC / Ipamorelin Blend. Click any row to download the full lab report PDF — third-party HPLC, USP<85> endotoxin, and USP<71> microbial testing.
| Size | Batch | Test Date | Purity | Endotox | Sterility | |
|---|---|---|---|---|---|---|
| 12mg | PC-G2-CJIP | 03/30/2026 | 99.05% | Pass | Pass | View PDF |
You May Also Like
CJC-1295 No DAC (Mod GRF 1-29)
Short-acting GHRH analogue (Modified GRF 1-29) for growth hormone research.
From $51.99
View DetailsPT-141 (Bremelanotide)
Melanocortin receptor agonist for research applications.
From $61.99
View DetailsKisspeptin-10
Neuropeptide for reproductive endocrinology research.
From $51.99
View Details